You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADT

Showing 26 - 50 of 622
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 12, 2023

Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Omaha, Nebraska
  • +4 more
Nov 10, 2022

Metastatic Hormone-Sensitive Prostate Cancer Trial in China (biological, drug, procedure, other)

Active, not recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +23 more
Sep 30, 2022

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial (procedure, dietary

Not yet recruiting
  • Stage I Prostate Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Apr 20, 2023

Prostate Cancer, Biochemical Recurrence Trial in Nanjing (Rezvilutamide, Androgen deprivation therapy (ADT), SRT)

Recruiting
  • Prostate Cancer
  • Biochemical Recurrence
  • Nanjing, Jiangsu, China
  • +1 more
Mar 2, 2023

Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

Recruiting
  • Salivary Gland Carcinoma
  • Chicago, Illinois
  • +6 more
Sep 22, 2022

Prostate Cancer Trial in Nanning (Darolutamide 300 mg, Androgen deprivation therapy)

Not yet recruiting
  • Prostate Cancer
  • Darolutamide 300 mg
  • Androgen deprivation therapy
  • Nanning, Jiangsu, China
    Hongqian Guo
Feb 19, 2022

Cancer of Prostate Trial in Ann Arbor (ADT ORDER CHECK ATTESTATION (OR), PROVIDER SCRIPT (SC))

Active, not recruiting
  • Cancer of Prostate
  • ADT ORDER CHECK ATTESTATION (OR)
  • PROVIDER SCRIPT (SC)
  • Ann Arbor, Michigan
    VA Ann Arbor Healthcare System
Nov 7, 2022

Prostate Cancer Trial in Nanjing (Abiraterone Acetate, Prednisone, Goserelin 10.8 mg)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Dec 14, 2022

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Prostate Cancer, Metabolic Syndrome, Obesity Trial (Apple Cider Vinegar, Placebo)

Not yet recruiting
  • Prostate Cancer
  • +6 more
  • Apple Cider Vinegar
  • Placebo
  • (no location specified)
Mar 24, 2023

Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy Trial in

Recruiting
  • Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer center
Dec 28, 2021

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Prostate Cancer Trial in Guildford (Exercise)

Not yet recruiting
  • Prostate Cancer
  • Exercise
  • Guildford, Surrey, United Kingdom
    University of Surrey
Aug 9, 2023

Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

Recruiting
  • Salivary Gland Cancer
  • Salivary Duct Carcinoma
  • 68Ga-PSMA-PET/CT
  • 18FDG-PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 15, 2022

Prostate Cancer Trial in Miami (FTLEAD, Ultra-Short-Term Androgen Deprivation Therapy with Relugolix, HypoLEAD)

Not yet recruiting
  • Prostate Cancer
  • FTLEAD
  • +3 more
  • Miami, Florida
    University of Miami
Oct 26, 2023

Prostate Cancer, Physical Function Trial in Boston (Progressive Resistance Training Exercise, Flexibility and Balance Exercise)

Recruiting
  • Prostate Cancer
  • Physical Function
  • Progressive Resistance Training Exercise
  • Flexibility and Balance Exercise
  • Boston, Massachusetts
  • +1 more
Nov 22, 2021

Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Androgen deprivation therapy (ADT)
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023

Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +5 more
Jul 14, 2022

Effect of ADT in Prostate Cancer Asia (READT Asia Study)

Recruiting
  • Prostate Cancer
  • Androgen deprivation therapy - bilateral orchidectomy
  • +2 more
  • Shatin, Hong Kong
    Prince of Wales Hospital
Dec 14, 2021

Recurrent Prostate Cancer Trial in Salisbury, Winston-Salem (MGE, Placebo, ADT)

Recruiting
  • Recurrent Prostate Cancer
  • Salisbury, North Carolina
  • +1 more
Nov 2, 2022

Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

Not yet recruiting
  • Prostate Cancer
  • Apalutamide Oral Product
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Mar 27, 2023

Prostate Cancer Trial in Worldwide (ODM-201, ADT)

Active, not recruiting
  • Prostate Cancer
  • Brussels, Belgium
  • +11 more
Jun 9, 2022

Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)

Not yet recruiting
  • Oligometastatic Prostate Carcinoma
  • ADT combined with abiraterone
  • neoadjuvant hormone and RT
  • Hefei, Anhui, China
  • +5 more
Jan 28, 2023

Prostatic Tumor Trial in Seoul (Docetaxel, Androgen-Deprivation Therapy (ADT))

Active, not recruiting
  • Prostatic Neoplasm
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 6, 2022